SELLAS LIFE SCIENCES GROUP I's ticker is SLS and the CUSIP is 81642T209. A total of 17 filers reported holding SELLAS LIFE SCIENCES GROUP I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460,177 | +3.4% | 280,596 | -1.0% | 0.00% | – |
| Q2 2023 | $444,888 | +19.0% | 283,368 | +8.4% | 0.00% | – |
| Q1 2023 | $373,920 | -39.0% | 261,483 | +0.6% | 0.00% | – |
| Q4 2022 | $613,376 | +18.6% | 259,905 | +1.4% | 0.00% | – |
| Q3 2022 | $517,000 | -9.9% | 256,260 | -0.5% | 0.00% | – |
| Q2 2022 | $574,000 | -66.0% | 257,505 | +1.8% | 0.00% | – |
| Q1 2022 | $1,689,000 | +19.9% | 252,891 | -0.8% | 0.00% | – |
| Q4 2021 | $1,409,000 | -39.1% | 254,844 | +0.8% | 0.00% | – |
| Q3 2021 | $2,315,000 | -17.4% | 252,838 | +0.1% | 0.00% | – |
| Q2 2021 | $2,803,000 | +30.5% | 252,480 | +0.4% | 0.00% | – |
| Q1 2021 | $2,148,000 | +268.4% | 251,555 | +150.5% | 0.00% | – |
| Q4 2020 | $583,000 | +119.2% | 100,424 | 0.0% | 0.00% | – |
| Q3 2020 | $266,000 | -9.5% | 100,424 | 0.0% | 0.00% | – |
| Q2 2020 | $294,000 | +69.0% | 100,424 | 0.0% | 0.00% | – |
| Q1 2020 | $174,000 | -59.7% | 100,424 | 0.0% | 0.00% | – |
| Q4 2019 | $432,000 | – | 100,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,250,000 | $1,787,500 | 0.02% |
| Alyeska Investment Group, L.P. | 1,000,000 | $1,430,000 | 0.01% |
| Opus Capital Group, LLC | 25,000 | $36 | 0.01% |
| Equitable Holdings, Inc. | 130,000 | $185,900 | 0.00% |
| VANGUARD GROUP INC | 896,912 | $1,282,584 | 0.00% |
| WealthPLAN Partners, LLC | 1 | $1 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,660 | $2,373 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 31,304 | $44,765 | 0.00% |
| WELLS FARGO & COMPANY/MN | 16,142 | $23,083 | 0.00% |
| NORTHERN TRUST CORP | 30,018 | $42,926 | 0.00% |